James C Yang

Landscape of Tumor Antigens in T Cell Immunotherapy

S. Ilyas, J. Yang, Sadia Ilyas, 2015, The Journal of Immunology.

Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research.

Emanuel F Petricoin, J Carl Barrett, W Marston Linehan, 2003, Clinical advances in hematology & oncology : H&O.

HPV-targeted tumor-infiltrating lymphocytes for cervical cancer.

Richard Sherry, S. Rosenberg, J. Yang, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Sadik H. Kassim, M. Raffeld, S. Rosenberg, 2014, Clinical Cancer Research.

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

John Mao, Francesco M Marincola, F. Marincola, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicities Associated With Adoptive T-Cell Transfer for Cancer.

J. Yang, James C Yang, 2015, Cancer journal.

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

Seth M Steinberg, S. Steinberg, S. Rosenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

S. Rosenberg, Alexandria P. Cogdill, R. Morgan, 2009, Blood.

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

Seth M Steinberg, S. Steinberg, Helen X. Chen, 2003, The New England journal of medicine.

Cancer immunotherapy: moving beyond current vaccines

S. Rosenberg, J. Yang, N. Restifo, 2004, Nature Medicine.

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

M. Raffeld, S. Rosenberg, R. Morgan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.